750 related articles for article (PubMed ID: 24378614)
1. Chimeric anti-IL-17 full-length monoclonal antibody is a novel potential candidate for the treatment of rheumatoid arthritis.
Bai F; Tian H; Niu Z; Liu M; Ren G; Yu Y; Sun T; Li S; Li D
Int J Mol Med; 2014 Mar; 33(3):711-21. PubMed ID: 24378614
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effects of interleukin-1β and interleukin-17A antibodies on collagen-induced arthritis mouse model.
Zhang Y; Ren G; Guo M; Ye X; Zhao J; Xu L; Qi J; Kan F; Liu M; Li D
Int Immunopharmacol; 2013 Feb; 15(2):199-205. PubMed ID: 23280345
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological efficacy of anti-IL-1β scFv, Fab and full-length antibodies in treatment of rheumatoid arthritis.
Qi J; Ye X; Ren G; Kan F; Zhang Y; Guo M; Zhang Z; Li D
Mol Immunol; 2014 Feb; 57(2):59-65. PubMed ID: 24091292
[TBL] [Abstract][Full Text] [Related]
4. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
5. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic efficacy of three bispecific antibodies on collagen-induced arthritis mouse model.
Li Q; Ren G; Xu L; Wang Q; Qi J; Wang W; Zhou B; Han X; Sun C; Wu Q; Yu Y; Peng Z; Zheng S; Li D
Int Immunopharmacol; 2014 Jul; 21(1):119-27. PubMed ID: 24800661
[TBL] [Abstract][Full Text] [Related]
7. Anti-IL-17A therapy protects against bone erosion in experimental models of rheumatoid arthritis.
Chao CC; Chen SJ; Adamopoulos IE; Davis N; Hong K; Vu A; Kwan S; Fayadat-Dilman L; Asio A; Bowman EP
Autoimmunity; 2011 May; 44(3):243-52. PubMed ID: 20925596
[TBL] [Abstract][Full Text] [Related]
8. Complementary action of granulocyte macrophage colony-stimulating factor and interleukin-17A induces interleukin-23, receptor activator of nuclear factor-κB ligand, and matrix metalloproteinases and drives bone and cartilage pathology in experimental arthritis: rationale for combination therapy in rheumatoid arthritis.
van Nieuwenhuijze AE; van de Loo FA; Walgreen B; Bennink M; Helsen M; van den Bersselaar L; Wicks IP; van den Berg WB; Koenders MI
Arthritis Res Ther; 2015 Jun; 17(1):163. PubMed ID: 26081345
[TBL] [Abstract][Full Text] [Related]
9. A bispecific antibody against IL-1β and IL-17A is beneficial for experimental rheumatoid arthritis.
Qi J; Kan F; Ye X; Guo M; Zhang Y; Ren G; Li D
Int Immunopharmacol; 2012 Dec; 14(4):770-8. PubMed ID: 23092552
[TBL] [Abstract][Full Text] [Related]
10. IL-17 increases cadherin-11 expression in a model of autoimmune experimental arthritis and in rheumatoid arthritis.
Park YE; Woo YJ; Park SH; Moon YM; Oh HJ; Kim JI; Jin HS; Baek SH; Kim GT; Lee JH; Cho ML; Kim SI
Immunol Lett; 2011 Oct; 140(1-2):97-103. PubMed ID: 21798287
[TBL] [Abstract][Full Text] [Related]
11. The suppressive effects of Saposhnikovia divaricata (Fangfeng) chromone extract on rheumatoid arthritis via inhibition of nuclear factor-κB and mitogen activated proteinkinases activation on collagen-induced arthritis model.
Kong X; Liu C; Zhang C; Zhao J; Wang J; Wan H; Zhu H; Zhang P; Chen W; Xiao Y; Lin N
J Ethnopharmacol; 2013 Jul; 148(3):842-50. PubMed ID: 23711830
[TBL] [Abstract][Full Text] [Related]
12. IL-1β and TNFα-initiated IL-6-STAT3 pathway is critical in mediating inflammatory cytokines and RANKL expression in inflammatory arthritis.
Mori T; Miyamoto T; Yoshida H; Asakawa M; Kawasumi M; Kobayashi T; Morioka H; Chiba K; Toyama Y; Yoshimura A
Int Immunol; 2011 Nov; 23(11):701-12. PubMed ID: 21937456
[TBL] [Abstract][Full Text] [Related]
13. Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1.
Koenders MI; Lubberts E; Oppers-Walgreen B; van den Bersselaar L; Helsen MM; Di Padova FE; Boots AM; Gram H; Joosten LA; van den Berg WB
Am J Pathol; 2005 Jul; 167(1):141-9. PubMed ID: 15972960
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis.
Palmer G; Talabot-Ayer D; Lamacchia C; Toy D; Seemayer CA; Viatte S; Finckh A; Smith DE; Gabay C
Arthritis Rheum; 2009 Mar; 60(3):738-49. PubMed ID: 19248109
[TBL] [Abstract][Full Text] [Related]
15. Kirenol exerts a potent anti-arthritic effect in collagen-induced arthritis by modifying the T cells balance.
Lu Y; Xiao J; Wu ZW; Wang ZM; Hu J; Fu HZ; Chen YY; Qian RQ
Phytomedicine; 2012 Jul; 19(10):882-9. PubMed ID: 22673798
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-interleukin-17 interplay induces S100A8, interleukin-1β, and matrix metalloproteinases, and drives irreversible cartilage destruction in murine arthritis: rationale for combination treatment during arthritis.
Koenders MI; Marijnissen RJ; Devesa I; Lubberts E; Joosten LA; Roth J; van Lent PL; van de Loo FA; van den Berg WB
Arthritis Rheum; 2011 Aug; 63(8):2329-39. PubMed ID: 21520013
[TBL] [Abstract][Full Text] [Related]
17. Treatment with anti-gamma-glutamyl transpeptidase antibody attenuates osteolysis in collagen-induced arthritis mice.
Ishizuka Y; Moriwaki S; Kawahara-Hanaoka M; Uemura Y; Serizawa I; Miyauchi M; Shibata S; Kanaya T; Takata T; Taniguchi N; Niida S
J Bone Miner Res; 2007 Dec; 22(12):1933-42. PubMed ID: 17680722
[TBL] [Abstract][Full Text] [Related]
18. The bispecific antibody aimed at the vicious circle of IL-1β and IL-17A, is beneficial for the collagen-induced rheumatoid arthritis of mice through NF-κB signaling pathway.
Wu Q; Wang Y; Wang Q; Yu D; Wang Y; Song L; Liu Z; Ye X; Xu P; Cao H; Li D; Ren G
Immunol Lett; 2016 Nov; 179():68-79. PubMed ID: 27616043
[TBL] [Abstract][Full Text] [Related]
19. α2β1 integrin regulates Th17 cell activity and its neutralization decreases the severity of collagen-induced arthritis.
El Azreq MA; Boisvert M; Cesaro A; Pagé N; Loubaki L; Allaeys I; Chakir J; Poubelle PE; Tessier PA; Aoudjit F
J Immunol; 2013 Dec; 191(12):5941-50. PubMed ID: 24244022
[TBL] [Abstract][Full Text] [Related]
20. IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation.
Joosten LA; Helsen MM; Saxne T; van De Loo FA; Heinegard D; van Den Berg WB
J Immunol; 1999 Nov; 163(9):5049-55. PubMed ID: 10528210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
